Human Receptor Tyrosine-Protein Kinase Erbb-4 (ERBB4) Protein

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Human Receptor Tyrosine-Protein Kinase Erbb-4 (ERBB4) Protein is a recombinant Human protein produced in a Mammalian cell expression system.
Documents del producto
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Receptor Tyrosine-Protein Kinase Erbb-4 (ERBB4) |
Host | Mammalian cells |
Origin | Human |
Conjugation | Unconjugated |
Observed MW | Molecular Weight: Calculated MW: 98.36 kDa Sequence Fragment: Gln26-His641 Tag: N-terminal Fc tag |
Expression | Recombinant |
Purity | > 90% (SDS-PAGE) |
Size 1 | 100 µg |
Size 2 | 1 mg |
Form | Lyophilized Reconstitute in sterile water to produce a stock solution. |
Tested Applications | ELISA, WB, SDS-PAGE |
Buffer | Prior to lyophilization: PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
Availability | Shipped within 5-12 working days. |
Storage | Store at 2-8 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C for long-term storage. Avoid repeated freeze-thaw cycles. |
Dry Ice | No |
UniProt ID | Q15303 |
Background | Protein ERBB4 |
Note | This product is for research use only. This product is shipped with ice packs. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human ERBB4 (Receptor tyrosine-protein kinase erbB-4) ELISA Kit
Ver Producto
Rat Erbb4 (Receptor tyrosine-protein kinase erbB-4) ELISA Kit
Ver Producto
ERBB4 antibody
This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized.
Ver Producto